Gastrointestinal stromal tumors: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

被引：189

作者：

Blay, Jean-Yves ^{[1
]}

Blomqvist, Carl ^{[1
]}

Bonvalot, Sylvie ^{[1
]}

Boukovinas, Ioannis ^{[1
]}

Casali, Paolo G. ^{[1
]}

De Alava, Enrique ^{[1
]}

Dei Tos, Angelo Paolo ^{[1
]}

Dirksen, Uta ^{[1
]}

Duffaud, Florence ^{[1
]}

Eriksson, Mikael ^{[1
]}

Fedenko, Alexander ^{[1
]}

Ferrari, Andrea ^{[1
]}

Ferrari, Stefano ^{[1
]}

Garcia del Muro, Xavier ^{[1
]}

Gelderblom, Hans ^{[1
]}

Grimer, Robert ^{[1
]}

Gronchi, Alessandro ^{[1
]}

Hall, Kirsten Sundby ^{[1
]}

Hassan, Bass ^{[1
]}

Hogendoorn, Pancras ^{[1
]}

Hohenberger, Peter ^{[1
]}

Issels, Rolf ^{[1
]}

Joensuu, Heikki ^{[1
]}

Jost, Lorenz ^{[1
]}

Jurgens, Heribert ^{[1
]}

Kager, Leo ^{[1
]}

Le Cesne, Axel ^{[1
]}

Leyvraz, Serge ^{[1
]}

Martin, Javier ^{[1
]}

Merimsky, Ofer ^{[1
]}

Nishida, Ofer ^{[1
]}

Picci, Piero ^{[1
]}

Reichardt, Peter ^{[1
]}

Rutkowski, Piotr ^{[1
]}

Schlemmer, Marcus ^{[1
]}

Sleijfer, Stefan ^{[1
]}

Stacchiotti, Silvia ^{[1
]}

Taminiau, Antoine ^{[1
]}

Wardelmann, Eva ^{[1
]}

机构：

[1] ESMO Head Off, CH-6962 Viganello, Switzerland

来源：

ANNALS OF ONCOLOGY | 2012年 / 23卷

关键词：

PHASE-II TRIAL; IMATINIB MESYLATE; ADVANCED/METASTATIC GIST; ADJUVANT IMATINIB; CARNEY-STRATAKIS; RANDOMIZED-TRIAL; DOSE IMATINIB; MUTATIONS; SURGERY; KINASE;

D O I：

10.1093/annonc/mds252

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页码：49 / 55

页数：7

共 37 条

[1] We should desist using RECIST, at least in GIST [J].

Benjamin, Robert S. ;

Choi, Haesun ;

Macapinlac, Homer A. ;

Burgess, Michael A. ;

Patel, Shreyaskumar R. ;

Chen, Lei L. ;

Podoloff, Donald A. ;

Charnsangavej, Chuslip .

JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (13) :1760-1764

[2] Long-term results from a randomized phase II trial of standard- versus higher-dose imatinib mesylate for patients with unresectable or metastatic gastrointestinal stromal tumors expressing KIT [J].

Blanke, Charles D. ;

Demetri, George D. ;

von Mehren, Margaret ;

Heinrich, Michael C. ;

Eisenberg, Burton ;

Fletcher, Jonathan A. ;

Corless, Christopher L. ;

Fletcher, Christopher D. M. ;

Roberts, Peter J. ;

Heinz, Daniela ;

Wehre, Elisabeth ;

Nikolova, Zariana ;

Joensuu, Heikki .

JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (04) :620-625

[3] Phase III randomized, intergroup trial assessing imatinib mesylate at two dose levels in patients with unresectable or metastatic gastrointestinal stromal tumors expressing the kit receptor tyrosine kinase: S0033 [J].

Blanke, Charles D. ;

Rankin, Cathryn ;

Demetri, George D. ;

Ryan, Christopher W. ;

von Mehren, Margaret ;

Benjamin, Robert S. ;

Raymond, A. Kevin ;

Bramwell, Vivien H. C. ;

Baker, Laurence H. ;

Maki, Robert G. ;

Tanaka, Michael ;

Hecht, J. Randolph ;

Heinrich, Michael C. ;

Fletcher, Christopher D. M. ;

Crowley, John J. ;

Borden, Ernest C. .

JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (04) :626-632

[4] Correlation of computed tomography and positron emission tomography in patients with metastatic gastrointestinal stromal tumor treated at a single institution with imatinib mesylate: Proposal of new computed tomography response criteria [J].

Choi, Haesun ;

Charnsangavej, Chuslip ;

Faria, Silvana C. ;

Macapinlac, Homer A. ;

Burgess, Michael A. ;

Patel, Shreyaskumar R. ;

Chen, Lei L. ;

Podoloff, Donald A. ;

Benjamin, Robert S. .

JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (13) :1753-1759

[5] KIT mutations and dose selection for imatinib in patients with advanced gastrointestinal stromal tumours [J].

Debiec-Rychter, Maria ;

Sciot, Raf ;

Le Cesne, Axel ;

Schlemmer, Marcus ;

Hohenberger, Peter ;

van Oosterom, Allan T. ;

Blay, Jean-Yves ;

Leyvraz, Serge ;

Stul, Michel ;

Casali, Paolo G. ;

Zalcberg, John ;

Verweij, Jaap ;

Van Glabbeke, Martine ;

Hagemeijer, Anne ;

Judson, Ian .

EUROPEAN JOURNAL OF CANCER, 2006, 42 (08) :1093-1103

[6] Adjuvant imatinib mesylate after resection of localised, primary gastrointestinal stromal tumour: a randomised, double-blind, placebo-controlled trial [J].

DeMatteo, Ronald P. ;

Ballman, Karla V. ;

Antonescu, Cristina R. ;

Maki, Robert G. ;

Pisters, Peter W. T. ;

Demetri, George D. ;

Blackstein, Martin E. ;

Blanke, Charles D. ;

von Mehren, Margaret ;

Brennan, Murray F. ;

Patel, Shreyaskumar ;

McCarter, Martin D. ;

Polikoff, Jonathan A. ;

Tan, Benjamin R. ;

Owzar, Kouros .

LANCET, 2009, 373 (9669) :1097-1104

[7]

Demetri G, 2012, J CLIN ONCOL S, V30

[8] Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors [J].

Demetri, GD ;

von Mehren, M ;

Blanke, CD ;

Van den Abbeele, AD ;

Eisenberg, B ;

Roberts, PJ ;

Heinrich, MC ;

Tuveson, DA ;

Singer, S ;

Janicek, M ;

Fletcher, JA ;

Silverman, SG ;

Silberman, SL ;

Capdeville, R ;

Kiese, B ;

Peng, B ;

Dimitrijevic, S ;

Druker, BJ ;

Corless, C ;

Fletcher, CDM ;

Joensuu, H .

NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (07) :472-480

[9] Efficacy and safety of sunitinib in patients with advanced gastrointestinal stromal tumour after failure of imatinib: a randomised controlled trial [J].

Demetri, George D. ;

van Oosterom, Allan T. ;

Garrett, Christopher R. ;

Blackstein, Martin E. ;

Shah, Manisha H. ;

Verweij, Jaap ;

McArthur, Grant ;

Judson, Ian R. ;

Heinrich, Michael C. ;

Morgan, Jeffrey A. ;

Desai, Jayesh ;

D Fletcher, Christopher ;

George, Suzanne ;

Bello, Carlo L. ;

Huang, Xin ;

Baum, Charles M. ;

Casali, Paolo G. .

LANCET, 2006, 368 (9544) :1329-1338

[10] Imatinib Plasma Levels Are Correlated With Clinical Benefit in Patients With Unresectable/Metastatic Gastrointestinal Stromal Tumors [J].

Demetri, George D. ;

Wang, Yanfeng ;

Wehrle, Elisabeth ;

Racine, Amy ;

Nikolova, Zariana ;

Blanke, Charles D. ;

Joensuu, Heikki ;

von Mehren, Margaret .

JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (19) :3141-3147

← 1 2 3 4 →